Rigel Pharmaceuticals, Inc.RIGLNASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Loading chart...

Alerts

Want to monitor RIGL?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

Create free account to monitor RIGL

Key Statistics

About

rigel pharmaceuticals, inc. , is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases.

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in Biotechnology (except Nanobiotechnology)

CEO

Raul Rodriguez

rigel.com/ →

News

DEADLINE NEXT WEEK: Berger Montague Advises Integer Holdings Corporation (NYSE: ITGR) Investors to Contact the Firm Before February 9, 2026

globenewswire.com

Perspective Therapeutics Announces Pricing of $175 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

globenewswire.com

Disney reeled in record streaming profits, boosted by price hikes

businessinsider.com

Realty Income Has Made 650 Consecutive Monthly Payments and the Streak Looks Secure

247wallst.com

Why I'm Even More Bullish About Berkshire Without Warren Buffett

247wallst.com

Venezuela's oil exports bounce to 800,000 bpd in January under US control -shipping data

reuters.com

Can Google Gemini Keep Up the Pace in 2026?

247wallst.com

Imperial Oil: Evaluation After Its Earnings Report

seekingalpha.com

Parex Resources: The Rebound Continues

seekingalpha.com

Birchtech Commences Enforcement of $78 Million Judgment Payment

globenewswire.com

Claros Mortgage Trust, Inc. Announces $500 Million Secured Term Loan Credit Facility

businesswire.com

Aftermath Silver Appoints Chief Operating Officer

newsfilecorp.com

Spectral AI to Participate in National Burn Awareness Week 2026 February 1–7, 2026

globenewswire.com

ScanTech AI Systems Launches Collaborative Pilot Program with the City of Atlanta, in Preparation for 2026 FIFA Football World Cup Events

globenewswire.com

Customers Bank Joins Qualia's Bank Partner Network

businesswire.com

IGC Pharma Reaches 70% Enrollment in Phase 2 CALMA Trial Evaluating IGC-AD1 for Alzheimer's Agitation

accessnewswire.com

Engaged Capital Formally Nominates Three Highly Qualified, Independent Director Candidates to the BlackLine Board

businesswire.com

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Alerts

Key Statistics

About

News

Idexx Laboratories (IDXX) Beats Q4 Earnings and Revenue Estimates

Digi Power X names former Verizon CEO Hans Vestberg as senior advisor

Allegro MicroSystems Sees Industrials Leading Growth

DEADLINE NEXT WEEK: Berger Montague Advises Integer Holdings Corporation (NYSE: ITGR) Investors to Contact the Firm Before February 9, 2026

Perspective Therapeutics Announces Pricing of $175 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

Disney reeled in record streaming profits, boosted by price hikes

Realty Income Has Made 650 Consecutive Monthly Payments and the Streak Looks Secure

Why I'm Even More Bullish About Berkshire Without Warren Buffett

Venezuela's oil exports bounce to 800,000 bpd in January under US control -shipping data

Can Google Gemini Keep Up the Pace in 2026?

Imperial Oil: Evaluation After Its Earnings Report

Parex Resources: The Rebound Continues

Birchtech Commences Enforcement of $78 Million Judgment Payment

Claros Mortgage Trust, Inc. Announces $500 Million Secured Term Loan Credit Facility

Aftermath Silver Appoints Chief Operating Officer

Spectral AI to Participate in National Burn Awareness Week 2026 February 1–7, 2026

ScanTech AI Systems Launches Collaborative Pilot Program with the City of Atlanta, in Preparation for 2026 FIFA Football World Cup Events

Customers Bank Joins Qualia's Bank Partner Network

IGC Pharma Reaches 70% Enrollment in Phase 2 CALMA Trial Evaluating IGC-AD1 for Alzheimer's Agitation

Engaged Capital Formally Nominates Three Highly Qualified, Independent Director Candidates to the BlackLine Board

Explore More

Idexx Laboratories (IDXX) Beats Q4 Earnings and Revenue Estimates

Digi Power X names former Verizon CEO Hans Vestberg as senior advisor

Allegro MicroSystems Sees Industrials Leading Growth

DEADLINE NEXT WEEK: Berger Montague Advises Integer Holdings Corporation (NYSE: ITGR) Investors to Contact the Firm Before February 9, 2026

Perspective Therapeutics Announces Pricing of $175 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

Disney reeled in record streaming profits, boosted by price hikes

Realty Income Has Made 650 Consecutive Monthly Payments and the Streak Looks Secure

Why I'm Even More Bullish About Berkshire Without Warren Buffett

Venezuela's oil exports bounce to 800,000 bpd in January under US control -shipping data

Can Google Gemini Keep Up the Pace in 2026?

Imperial Oil: Evaluation After Its Earnings Report

Parex Resources: The Rebound Continues

Birchtech Commences Enforcement of $78 Million Judgment Payment

Claros Mortgage Trust, Inc. Announces $500 Million Secured Term Loan Credit Facility

Aftermath Silver Appoints Chief Operating Officer

Spectral AI to Participate in National Burn Awareness Week 2026 February 1–7, 2026

ScanTech AI Systems Launches Collaborative Pilot Program with the City of Atlanta, in Preparation for 2026 FIFA Football World Cup Events

Customers Bank Joins Qualia's Bank Partner Network

IGC Pharma Reaches 70% Enrollment in Phase 2 CALMA Trial Evaluating IGC-AD1 for Alzheimer's Agitation

Engaged Capital Formally Nominates Three Highly Qualified, Independent Director Candidates to the BlackLine Board

Key Statistics